How does trial enrollment work? Does big pharma ki
Post# of 148179
When a drug like Remdesivir is showing poor at best results and yet dominates all the trials over and over since they continue to trial. Is that just to keep other drug companies from filling their very own trials and delay all other drugs to progress. Is this about who has the most money to back their drug? Does this next huge trial enrollment show something better? Do you do finally find a trial that shows something good and cancel the trials that are not working like Gilead has canceled multiple trials where they weren’t performing well. The next large trial with 5600 worldwide to be enrolled soon by Gilead. Is it preventing better drugs from progressing and therefore killing people? Is there blood on Gileads hands? The FDA for promoting such a minimal successful drug? This is what it seems and why does the federal government allow such a treachery? Buying your own trial results.
Link: https://www.bizjournals.com/sanfrancisco/news...t-and.html
Quote from article:
What now? Gilead likely will get accelerated approval. Meanwhile, it added an expansion phase of its study that will enroll an additional 5,600 patients at 180 trial sites globally. A second SIMPLE study is looking at the safety and efficacy of five- and 10-day treatments of remdesivir in patients with "moderate" Covid-19, with the results from the first 600 in that study expected by the end of May.